Standard Biotools Inc Stock Forecast, Predictions & Price Target

Analyst price target for LAB

Based on 1 analyst offering 12 month price targets for Standard Biotools Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell LAB stock?

Based on 1 analyst offering ratings for Standard Biotools Inc.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LAB stock forecasts and price targets.

LAB vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
LAB$2.03$10.00+392.61%Strong Buy

Standard Biotools Stock Forecast FAQ

Is Standard Biotools Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LAB) stock is to Strong Buy LAB stock.

Out of 1 analyst, 1 (100%) are recommending LAB as a Strong Buy, 0 (0%) are recommending LAB as a Buy, 0 (0%) are recommending LAB as a Hold, 0 (0%) are recommending LAB as a Sell, and 0 (0%) are recommending LAB as a Strong Sell.

If you're new to stock investing, here's how to buy Standard Biotools stock.

What is LAB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LAB price target, the average LAB price target is $10.00, with the highest LAB stock price forecast at $10.00 and the lowest LAB stock price forecast at $10.00.

The Wall Street analyst predicted that Standard Biotools's share price could reach $10.00 by Aug 9, 2022. The average Standard Biotools stock price prediction forecasts a potential upside of 392.61% from the current LAB share price of $2.03.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.